Kuala lumpur: Healthcare financing and wellness travel institution, Amden Capital Sdn Bhd, is recognizing South Korea as a burgeoning destination for international patients seeking specialized medical treatments. This trend is especially notable among Malaysians and others looking for expertise in areas where South Korea excels, such as advanced technology and procedural experience.
According to BERNAMA News Agency, in a recent exclusive interview, Ranjit Singh, CEO of Amden Capital, outlined South Korea's specialized capabilities in plastic and reconstructive surgery, aesthetic treatments, and other medical fields like oncology and orthopaedics. The emphasis is on promoting South Korea for specific treatments rather than a broad range, focusing on areas where the country offers a definitive advantage.
Singh elaborated on the institution's strategy, stating that while Malaysia remains a crucial market, Amden Capital aims to expand its services internationally. Since 2025, the company has been establishing its presence across Southeast Asia, seeking to serve a broader patient base.
He highlighted South Korea's competitive edge due to its specialized medical expertise, cutting-edge technology, and robust healthcare infrastructure. Singh advised patients to consider the full spectrum of treatment value, including technological and safety aspects, rather than merely focusing on cost.
Amden Capital has introduced the Care Verified by Amden Capital initiative, providing an extra level of transparency for patients contemplating treatment in South Korea. This initiative ensures that patients have a coordinated experience encompassing communication, appointments, and aftercare.
Amden Capital's collaboration with the Korea Health Industry Development Institute (KHIDI) has been instrumental in establishing a seamless communication channel for verifying hospital and specialist credentials. The firm has also signed 16 memoranda of understanding with various organizations in Gwangju, Busan, and Jeju, aiming to create a comprehensive healthcare travel ecosystem.
Care Verified is accessible to all potential patients, offering an additional verification layer without replacing professional medical advice. Singh emphasized the need for individual assessment to ensure the suitability of treatment and travel for each patient.
Singh concluded by stating Amden Capital's long-term goal to become a trusted international healthcare and medical travel institution, facilitating cross-border patient-provider connections.